Offline
Buy Dishman Pharmaceuticals: Vijay
Published on Wed, Jun 18, 2008 at 11:24 , Updated at Wed, Jun 18, 2008 at 11:40
Source : CNBC-TV18
| ads by google |
Portfolio Manager, PN Vijay is of the view that one can buy Dishman Pharmaceuticals. Vijay told CNBC-TV18, "In the midcap pharma Custom Research and Manufacturing Services (CRAMS) space for example Dishman is a great stock. They have gone in a big way into an inorganic growth in the CRAMS space, which is a high technology, high research driven space and the market is not fully valued that. So one could buy into Dishman as a research cum export story. One could also look at Nicholas, Jubilant and DVS but to my mind right now I think Dishman appears the best." Disclosure: It is safe to assume that analyst and his client may have an investment interest in the above stock/sector. |
|
Stock Advice
|
Messages on Dishman Pharma
Other comments
The loss shown this quarter is mainly on account forex fluctuations. With the rupee going to stabiliz against dolla...
in Dishman Pharma - jaish at 11-Nov-08 09:48
Heavy sellings by institutes causing the weakness in the counter.......
in Dishman Pharma - marketman at 01-Nov-08 06:47
Rate this article
News
No News on Dishman Pharma
Notices
24-10 Dishman Pharmaceuticals & Chemicals...
28-08 Dishman Pharmaceuticals And Chemica...
Management Interviews
25-01 Dishman Pharma looking at above 30%...
02-11 To add EUR 20 m to topline in FY09:...
Brokerage Reports
13-11 Buy Dishman Pharma, target Rs 185: ...
10-11 Buy Dishman Pharma; target Rs 247.6...
Technical Calls
No Technical Calls on Dishman Pharma
| ||||||||
Chat
Ramesh Damani
Member BSE ,
(18 Nov- 16:00hrs)
What's good investment now?
Poll
Newsletter
Keep in touch with News day & night. Subscribe to:
Mobile Services
Get news on the move SMS to 52622
- SMS M for Market News
- SMS B for Latest Business News
- SMS S (stock name) for latest news